КЛИНИКО-ИНСТРУМЕНТАЛЬНАЯ ОЦЕНКА МОРФО-ФУНКЦИОНАЛЬНОГО СОСТОЯНИЯ СЕРДЦА И СОСУДОВ ПРИ КОМОРБИДНОСТИ АГ И СД-2
Аннотация
Об авторе
Н. З. Бабаева
Научно-исследовательский Институт Кардиологии им. акад. Д. Абдуллаева
Азербайджан
Азербайджан
докторант (аспирант)
Телефон: +994125646978
Улица Фатали Хан Хойски, 101а, Баку, Азербайджан AZ1072
Список литературы
1. Рекомендации Европейского общества кардиологов и Европейского общества по артериальной гипертонии, 2018;
2. GBD 2017 Risk Factor Collaborators. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 2018; 392:1923.
3. Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension 2018; 71:e13.
4. Angeli F, Reboldi G, Verdecchia P. Hypertension, inflammation and atrial fibrillation. J Hypertens 2014; 32:480.
5. Iciar Martín-Timón, Cristina Sevillano-Collantes, Amparo Segura-Galindo, and Francisco Javier del Cañizo-Gómez Type 2 diabetes and cardiovascular disease: Have all risk factors the same strength? World J Diabetes. 2014 Aug 15; 5(4): 444–470. doi: 10.4239/wjd.v5.i4.444
6. Nilsson PM, Cederholm J, Zethelius BR, Eliasson BR, EegOlofsson K, Gudbj Rnsdottir S. Trends in blood pressure control in patients with type 2 diabetes: data from the Swedish National Diabetes Register (NDR) Blood Press. 2011;20:348–354. [PubMed]
7. Redon J, Cifkova R, Laurent S, Nilsson P, Narkiewicz K, Erdine S, Mancia G. Mechanisms of hypertension in the cardiometabolic syndrome. J Hypertens. 2009;27:441–451. [PubMed]
8. Speranza Rubattu, Beniamino Pagliaro, Giorgia Pierelli, Caterina Santolamazza, Sara Di Castro,Silvia Mennuni, and Massimo VolpePathogenesis of Target Organ Damage in Hypertension: Role of Mitochondrial Oxidative Stress. Int J Mol Sci. 2015 Jan; 16(1): 823–839. doi: 10.3390/ijms16010823
9. Walker AM, Patel PA, Rajwani A, Groves D, Denby C, Kearney L, Sapsford RJ, Witte KK, Kearney MT, Cubbon RM. Diabetes mellitus is associated with adverse structural and functional cardiac remodelling in chronic heart failure with reduced ejection fraction. Diab Vasc Dis Res. 2016 Sep;13(5):331-40. doi: 10.1177/1479164116653342.
10. Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation. 1977 Apr;55(4):613-8.
11. Куликов В.П. Цветное дуплексное сканирование в диагностике сосудистых заболеваний. //Новосибирск, 1997, с. 6-155.
12. Arning C, Widder B, von Reutern GM, Steigler H, Gortler M. Ultraschallkriterien zur Graduierung von Stenosen der A. carotis interna—Revision der DEGUM-Kriterien und Transfer in NASCET-Stenosierungsgrade. Ultraschall Med. 2010;31:251–257. doi: 10.1055/s-0029-1245336.
13. Von Reutern GM, Goertler MW, Bornstein NM, Del Sette M, et al. Grading carotid stenosis using ultrasonic methods. Stroke. 2012;43:916–921. doi: 10.1161/STROKEAHA.111.636084.
14. Gu K, Cowie CC, Harris MI. Diabetes and decline in heart disease mortality in US adults. JAMA. 1999;281:1291–1297. [PubMed]
15. Jialal I, Devaraj S, Venugopal SK. Oxidative stress, inflammation, and diabetic vasculopathies: the role of alpha tocopherol therapy. Free Radic Res. 2002;36:1331–1336. [PubMed]
16. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature. 2001;414:813–820. [PubMed]
17. Witztum JL, Steinberg D. Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest. 1991;88:1785–1792. [PMC free article] [PubMed]
18. Devaraj S, Jialal I. Oxidized low-density lipoprotein and atherosclerosis. Int J Clin Lab Res. 1996;26:178–184. [PubMed]
19. Fonseca V, Desouza C, Asnani S, Jialal I. Nontraditional risk factors for cardiovascular disease in diabetes. Endocr Rev. 2004;25:153–175.
20. Chapman MJ, Ginsberg HN, Amarenco P, Andreotti F, Borén J, Catapano AL, Descamps OS, Fisher E, Kovanen PT, Kuivenhoven JA, et al. Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management. Eur Heart J. 2011;32:1345–1361. [PMC free article] [PubMed]
21. Miller M, Stone NJ, Ballantyne C, Bittner V, Criqui MH, Ginsberg HN, Goldberg AC, Howard WJ, Jacobson MS, Kris-Etherton PM, et al. Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association. Circulation. 2011;123:2292–2333. [PubMed]
22. Djaberi R, Schuijf JD, Jukema JW, Rabelink TJ, Stok-kel MP, Smit JW, et al. Increased carotid intimamedia thickness as a predictor of the presence and extent of abnormal myocardial perfusion in type 2 diabetes. Diabetes Care. 2009; 33(2):372-374.
23. Marinchev A, Kamenova P. Relationship of insulin sensitivity with carotid intima media thickness in patients with type 2 diabetes mellitus. European Congress of Endocrinology. Endocrine Abstracts. 2008;(16):209.
24. Sunil Kumar Kota, Girija Ballav Mahapatra, Siva Krishna Kota, Syed Naveed, Prabhas Rranjan Tripathy,Sruti Jammula, and Kirtikumar D. Modi Carotid intima media thickness in type 2 diabetes mellitus with ischemic stroke. Indian J Endocrinol Metab. 2013 Jul-Aug; 17(4): 716–722. doi: 10.4103/2230-8210.113767.
Рецензия
Для цитирования:
Бабаева Н.З. КЛИНИКО-ИНСТРУМЕНТАЛЬНАЯ ОЦЕНКА МОРФО-ФУНКЦИОНАЛЬНОГО СОСТОЯНИЯ СЕРДЦА И СОСУДОВ ПРИ КОМОРБИДНОСТИ АГ И СД-2. Евразийский Кардиологический Журнал. 2019;(2):64-75. https://doi.org/10.38109/2225-1685-2019-2-64-75
For citation:
Babayeva N.Z. CLINICAL AND INSTRUMENTAL ASSESSMENT OF MORPHO-FUNCTIONAL CONDITION OF THE HEART AND VASCULATURE IN COMORBIDITY OF ARTERIAL HYPERTENSION AND DIABETES MELLITUS TYPE 2. Eurasian heart journal. 2019;(2):64-75. https://doi.org/10.38109/2225-1685-2019-2-64-75
Просмотров: 174
Послать статью по эл. почте 
